[Anxiety in ambulatory and hospital practice: effects of a new anxiolytic agent, bromazepam, in a homogeneous series of 30 patients (author's transl)].
Anxiety, a common complaint, may become pathological and troublesome in some subjects. The purpose of this study was to evaluate the effectiveness and safety of a new anxiolytic agent, bromazepam. Thirty patient (15 men and 15 women) with anxiety were given bromazepam 8 to 24 mg/day (depending on the results) in 4 divided doses. Therapeutic results were assessed by means of the Hamilton scale at weekly intervals in hospital patients and after 6 weeks' treatment in out-patients. Highly satisfactory results were obtained in 18 patients, half showed a favourable response as early as the 7th day of treatment. The best responses were obtained in subjects with neurotic reactional anxiety or with mild to moderate anxiety. Tolerance of the drug was excellent in the majority of cases.
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D001960:Bromazepam / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged
D014151:Anti-Anxiety Agents; D001960:Bromazepam
L'angoisse en pratique ambulatoire et hospitalière. Effets d'un nouvel anxiolytique, le bromazépam. Trente observations.